Tag:
BioCritica
Latest Headlines
Latest Headlines
"Lilly effect" helps drive a life sciences boom in Indiana
Call it the "Lilly effect." The Wall Street Journal mapped out several places in America which have thrived in spite of a sour economy and quickly zeroed in on Indiana's booming life sciences
Lilly launches new venture to market Xigris
What to do with an underperforming drug? If you're Eli Lilly, you start a new company to sell it. The Indianapolis-based company has licensed the U.S. rights to Xigris , a treatment for sepsis, to
Lilly spins off sepsis drug into a biotech start-up
Eli Lilly has inked a deal with a pair of investors--Care Capital and NovaQuest Capital--to spin off a sepsis drug into a new biotech in Indiana dubbed BioCritica which plans to build a pipeline of
